Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
DEMAND for fat jabs could overwhelm the NHS, the head of the health service has warned as Sir Keir Starmer piled hopes on using them to get obese jobseekers back to work. Amanda Pritchard, CEO of ...
Conclusion: The Karnataka High Court, upholding the ITAT’s order, reiterated that discounts on the issuance of ESOPs are allowable deductions under Section 37 (1) of the Income Tax Act, in line with ...
A study will assess changes in employment status and sick days when people take the drug. Weight loss drugs could be given to unemployed people with obesity as a way of getting them into work, British ...
Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.
AZN currently has a forward P/E ratio of 19.02, while NVO has a forward P/E of 39.15. We also note that AZN has a PEG ratio of 1.43. This metric is used similarly to the famous P/E ratio, but the PEG ...